Johnson & Johnson (JNJ) Financials

JNJ Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 167.6 billion 98.8 billion
2023-09-30 166.1 billion 94.8 billion
2023-06-30 191.7 billion 115.3 billion
2023-03-31 196.0 billion 125.1 billion

JNJ Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 6.3 billion 178.0 million
2023-09-30 6.5 billion 296.0 million
2023-06-30 3.1 billion 382.0 million
2023-03-31 2.4 billion 306.0 million

JNJ Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 4.1 billion
2023-09-30 26.0 billion
2023-06-30 5.1 billion
2023-03-31 -68.0 million

JNJ Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 22.9 billion - -
2023-09-30 23.5 billion 26.1 billion -
2023-06-30 28.5 billion 33.9 billion -
2023-03-31 32.3 billion 34.9 billion -

JNJ Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 2.4 billion
2023-09-30 2.5 billion
2023-06-30 2.6 billion
2023-03-31 2.6 billion

JNJ Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1.6 billion 4.5 billion 5.8 billion -
2023-09-30 967.0 million 3.4 billion 5.4 billion -
2023-06-30 1.1 billion 3.8 billion 6.7 billion -
2023-03-31 863.0 million 3.6 billion 5.7 billion 400.0 million

JNJ Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 21.4 billion 7.0 billion
2023-09-30 21.3 billion 6.5 billion
2023-06-30 25.5 billion 8.2 billion
2023-03-31 24.7 billion 8.2 billion

JNJ

List: Champions

Price: 162.23USD

52 week price:
143.80
175.97

Dividend Yield: 3.02%

5-year range yield:
2.39%
3.25%

Forward Dividend Yield: 2.95%

Payout Ratio: 89.31%

Payout Ratio Range:
40.69%
589.80%

Dividend Per Share: 4.76 USD

Earnings Per Share: 5.20 USD

P/E Ratio: 30.40

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 6.9 million

Ebitda: 2.9 billion

Market Capitalization: 380.2 billion

Average Dividend Frequency: 4

Years Paying Dividends: 63

DGR3: 5.62%

DGR5: 5.76%

DGR10: 5.98%

DGR20: 8.12%

Links: